Jones, Ceri Hopcyn
2018.
The role of telomere dysfunction in modulating disease progression and response to treatment in chronic lymphocytic leukaemia.
PhD Thesis,
Cardiff University.
Item availability restricted. |
Pepper, C., Buggins, A. G.S., Jones, C. H., Walsby, E. J. ORCID: https://orcid.org/0000-0001-8523-5017, Forconi, F., Pratt, G., Devereux, S., Stevenson, F. and Fegan, C. ORCID: https://orcid.org/0000-0001-9685-0621 2015. Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition. Leukemia 29 , pp. 744-747. 10.1038/leu.2014.308 |
Walsby, Elisabeth ORCID: https://orcid.org/0000-0001-8523-5017, Buggins, Andrea, Devereux, Stephen, Jones, Ceri, Pratt, Guy, Brennan, Paul ORCID: https://orcid.org/0000-0001-8792-0499, Fegan, Chris ORCID: https://orcid.org/0000-0001-9685-0621 and Pepper, Chris 2014. Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia. Blood 123 (23) , pp. 3607-3617. 10.1182/blood-2013-12-544569 |
Jones, Ceri H., Taylor, M. and McWilliams, B. 2013. The role of cetuximab as first-line treatment of colorectal liver metastases. HPB 15 (1) , pp. 11-17. 10.1111/j.1477-2574.2012.00591.x |
Jones, Ceri H., Pepper, Christopher John and Baird, Duncan Martin ORCID: https://orcid.org/0000-0001-8408-5467 2012. Telomere dysfunction and its role in haematological cancer. British Journal of Haematology 156 (5) , pp. 573-587. 10.1111/j.1365-2141.2011.09022.x |